3 ms·

Is public perception the greater problem, or delivery? My outsider read has been relatively few diseases can be targeted right now due to payload delivery obsta

• a_bonobo 2mo ago
  Yes, getting the drug into the right cell or tissue is still largely unsolved (kidney is easier than brain, of course). But the investors we talk with have dropped all interest in gene editing, too risky. RNA-based technologies are great, though - ASOs, siRNAs etc. Investors are very happy with those :)